Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure

The American Journal of Cardiology

Volumn 76, Issue 10, 1995, Pages 679-683

  Dickstein, Kenneth ^a,b,c,d   Larsen, Alf Inge ^a,b,c,d   Bonarjee, Vernon ^a,b,c,d   Thoresen, Magne ^a,b,c,d   Aarsland, Torbjørn ^a,b,c,d   Hall, Christian ^a,b,c,d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b Medstat Research   (Norway)

^c Hjertelaget Research Foundation   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; ATRIAL NATRIURETIC FACTOR DERIVATIVE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HORMONE PRECURSOR; NITRIC ACID DERIVATIVE; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUID RETENTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMAN; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; PULMONARY WEDGE PRESSURE; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 0029091708     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80196-9     Document Type: Article

References (29)

1. How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure?
2. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
3. The propeptide Asn 1-Tyr 126 is the storage form of rat atrial natriuretic factor
4. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor
5. Atrial natriuretic peptide and atrial pressures in patients with congestive heart failure
6. The role of atrial pressures in secreting atrial natriuretic polypeptides
7. Comparative vasoactive effects of native and synthetic atrial natriuretic factor (NAF)
8. Identification and plasma concentrations of the N-terminal fragment of atrial natriuretic factor in man
9. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure
10. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man
11. Plasma atrial natriuretic peptide in cardiac impairment
12. Plasma atrial natriuretic polypeptide as an index of LV end-diastolic pressure in patients with chronic left-sided heart failure
13. Comparative study of atrial peptides ANF (1–98) and ANF (99–126) as diagnostic markers of atrial distension in patients with cardiac disease
14. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
15. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction
16. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation
17. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
18. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
19. The plasma concentration of N-terminal proatrial natriuretic factor ANF(1–98) is related to prognosis in severe heart failure
20. Prognostic significance of N-terminal proatrial natriuretic factor (1–98) in acute myocardial infarction: comparison with atrial natriuretic factor (99–126) and clinical evaluation
21. Plasma proatrial natriuretic factor (1–98) concentration after myocardial infarction: relation to indices of cardiac and renal function
22. Metabolic clearance rate and plasma half-life of α-human atrial natriuretic peptide in man
23. Plasma atrial natriuretic peptide is unstable under most storage conditions
24. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine
25. NH2-terminal fragment of rat proatrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life
26. Activation of neurohumoral systems following acute myocardial infarction
27. Plasma atrial natriuretic factor in patients with acute myocardial infarction
28. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study
29. Normalization of circulating atrial peptides in cardiac transplant recipients